RNWL
INTERNATIONAL REGISTRATION RENEWED
05/21/2026
Back to search
Official data from USPTO
XINTELA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
XINTELA
ST13
US500000079193092Class
1, 5, 42
Filing
79193092
Registration
5603594
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
60
Latest update
05/22/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
05/10/2016
Registration date
11/13/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2025
Last transaction
05/22/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
LUND, SE
Examiner
LEE, DOUGLAS
Current location
Historical data usage
Holders and representatives
Holders
Xintela AB
Xintela AB
Representatives
Julie A. Greenberg Reising Ethington P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells for research and scientific purposes; antibodies for research and industrial purposes; DNA and RNA for scientific and industrial purposes; proteins for use within science; kit consisting of stem cellsantibodies and proteins for scientific and industrial purposes
Class 5
Stem cells for medical and veterinary purposes; DNA and RNA for medical and veterinary purposes; surgical implants comprised of living tissuesstem cells grown from stem cells; antibodies for medical purposes; biological preparations for the treatment of malignant tumoursbiological preparations for use as marker or target of all kinds of cells for therapeutic or diagnostic use and for use as marker or target in different physiological or therapeutic methods for therapeutic or diagnostic use; kit consisting of stem cellsantibodies and proteins for medical and veterinary purposes; all of the foregoing excluding Pharmaceutical preparations for use in the treatment and/or management of sleep disorders
Class 42
Scientific research services; laboratory research services in the field of medicinechemistrystem cellsDNARNAantibodies and proteins; quality control for others
Publications
History of USPTO decisions and trademark events.
60 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/25/2026
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
06/25/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
06/25/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/18/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
03/03/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/07/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/15/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/21/2019
FIMP
FINAL DISPOSITION PROCESSED
02/21/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/13/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/25/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/25/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
11/13/2018
TMBN
TTAB RELEASE CASE TO TRADEMARKS
10/04/2018
OP.T
OPPOSITION TERMINATED NO. 999999
10/04/2018
OP.D
OPPOSITION DISMISSED NO. 999999
10/04/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/07/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/23/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/07/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/07/2018
RFNP
REFUSAL PROCESSED BY IB
11/24/2017
OP.I
OPPOSITION INSTITUTED NO. 999999
11/02/2017
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
11/02/2017
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
11/02/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/31/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
08/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2017
PUBO
PUBLISHED FOR OPPOSITION
07/04/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/14/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/31/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/22/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
05/16/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/16/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
05/16/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/16/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2017
ALIE
ASSIGNED TO LIE
04/28/2017
ALIE
ASSIGNED TO LIE
04/16/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/04/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/02/2017
RFNT
REFUSAL PROCESSED BY IB
11/18/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/28/2016
RFRR
REFUSAL PROCESSED BY MPU
10/28/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/19/2016
CNRT
NON-FINAL ACTION WRITTEN
10/18/2016
MAFR
APPLICATION FILING RECEIPT MAILED
10/15/2016
DOCK
ASSIGNED TO EXAMINER
10/11/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/11/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/06/2016
Continuous trademark protection
Get notified about every new filing that threatens XINTELA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.